Dynavax Technologies Corporation (DVAX) Social Stream



Dynavax Technologies Corporation (DVAX): $11.25

-0.38 (-3.27%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add DVAX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 373

in industry

DYNAVAX TECHNOLOGIES CORP (DVAX) Price Targets From Analysts

Use the tables below to see what analysts covering DYNAVAX TECHNOLOGIES CORP think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 3 $30 $23 $26.5 $11.61 128.25%
2022-05-09 3 $30 $28 $29 $11.61 149.78%
2022-08-08 4 $38 $28 $32 $11.61 175.62%
2022-10-20 5 $38 $22 $29.5 $11.61 154.09%
2022-11-04 5 $30 $21 $25.25 $11.61 117.48%
2022-11-07 5 $28 $21 $24 $11.61 106.72%

The Trend in the Analyst Price Target


DVAX's average price target has moved up $5.33 over the prior 16 months.

Over the past 45 weeks, DVAX's average upside potential has been 154.83%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-03-02 3 30 28 29 12.58 130.52%
2022-05-09 4 30 28 29 8.17 254.96%
2022-05-09 3 38 28 32 8.17 291.68%
2022-08-05 4 38 28 32 16.65 92.19%
2022-11-04 5 28 21 24 12.58 90.78%

DVAX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 5 0 0 0 0 5

The Trend in the Broker Recommendations


DVAX's average broker recommendation rating improved by 0 over the prior 61 days.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • DYNAVAX TECHNOLOGIES CORP's number of analysts covering the stock is higher than 136.03% of all US stocks.
  • DVAX has a greater upside potential (average analyst target price relative to current price) than 535.96% of all US stocks.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, DYNAVAX TECHNOLOGIES CORP's variance in analysts' estimates is lower than -41.66% of them.
  • In terms of how DYNAVAX TECHNOLOGIES CORP fares relative to stocks in the mid market cap category, note that its average analyst price target is greater than 265.99% of that group.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to DYNAVAX TECHNOLOGIES CORP are TGTX, OPK, and MNKD.

Is DVAX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6677 seconds.